A Look at What’s Next After ESC
October 19, 2022 | Medscape, cardiology, medical education
This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data and guidelines presented at the conference. It had been three years since the last live ESC in Paris, where Medscape Education Global held an education event at the Eiffel Tower. In that time, Medscape Education Global saw their experience in cardiovascular grow, as well as their membership expand to over 5 million physicians and 11 million HCPs worldwide as new acquisitions joined the Medscape Professional Network.
Drs Keith A. A. Fox, MBChB, FRCP; Ileana Pena, MD; James L. Januzzi, MD, FACC, FESC and Lale Tokgozoglu, MD, FACC, FESC presented a panel discussion covering:
- The results of the INVICTUS-VKA trial, which examined the use of direct oral anticoagulant (DOAC) compared to a vitamin K antagonist in patients who have both rheumatic heart disease and atrial fibrillation
- The PACIFIC and AXIOMATIC-SSP trials for anti-XIa and lowering the bleeding risk
- The use of home and wearable devices for the detection of atrial fibrillation. You can get a copy of the latest 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) here.
- New information for the detection and management of atherosclerotic disease and measurement of lipoprotein
- New information for the management of CV disease in asymptomatic patients
You can view the whole panel discussion below or click here to watch it on YouTube.
All 2022 ESC guidelines can be found here.
Medscape Cardiology is committed to advancing outcomes with education. To discuss Cardiology education please contact Jelena Spyropoulos: email jspyropoulos@medscape.net or mobile +11 212-417-9572
About Medscape Education:
Medscape Education (medscape.org) delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. Medscape Education is the leading online global destination for physicians and healthcare professionals, providing over 5 million members with the latest medical news, expert opinion, and precision education (CME and CPD) to improve clinical practice and advance health outcomes. Medscape’s unrivalled membership reach and therapeutic expertise deliver education across 30+ specialties in 40+ learning formats, using the latest digital and live technology. Medscape is a subsidiary of WebMD Health Corp.
About WebMD
WebMD Health Corp., an Internet Brands Company, is the leading provider of health information services, serving patients, physicians, health care professionals, employers, and health plans through our public and private online portals, mobile platforms, and health-focused publications. The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and other owned WebMD sites. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org®, and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.
This content was provided by Medscape Education Global
Company Details
Latest Content from Medscape Education Global
Medscape Education and M4RD: Together Caring for Rare Disease
We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...
The Need for and Impact of Rare Disease Education
Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...
Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva
Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...
Medscape Education: Rare Diseases
It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...
Together Caring for Rare Disease
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC
This year's winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
ESMO's New Focus on Cancer Prevention
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...